ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE nod for breast cancer delay drug pharmatimes
April 02, 2019The National Institute for Health and Care Excellence (NICE) has recommended Eli Lilly’s Verzenio (abemaciclib) when given with Faslodex (fulvestrant), to be available for NHS use within the Cancer Drugs Fund (CDF).
Pharma Sources Insight January 2025
